Assessing the Feasibility, Acceptability, and Effectiveness of a Pilot Hepatitis C Screening Program at Food Distribution Sites in Cherokee Nation, Oklahoma
-
Published:2023-08-02
Issue:6
Volume:48
Page:982-993
-
ISSN:0094-5145
-
Container-title:Journal of Community Health
-
language:en
-
Short-container-title:J Community Health
Author:
Essex WhitneyORCID, Mera Jorge, Comiford Ashley, Winters Amanda, Feder Molly A
Abstract
AbstractCompared with other racial and ethnic groups in the United States, American Indian and Alaska Native (AI/AN) people experience the highest incidence of acute hepatitis c (HCV). Cherokee Nation Health Services (CNHS) implemented a pilot health screening program from January through May 2019 to assess whether conducting HCV and other preventive health screenings at food distribution sites is a feasible, acceptable, and effective strategy to increase health screening among underserved community members. Data were collected among 340 eligible participants. Most (76%) participants reported being very comfortable receiving health screenings at food distribution sites and that getting screened at food distribution sites is very easy (75.4%). Most (92.1%, n = 313) participants received HCV screening, with 11 (3.5%) individuals testing positive for HCV antibodies. Of the 11 HCV seropositive individuals, six were confirmed to have active HCV infection of which four initiated treatment. Most (55.7%) participants exhibited a body mass index in the obese range, 33.1% exhibited high hemoglobin A1C (> 6.0), 24.5% exhibited high (> 200) cholesterol, 44.6% exhibited high blood pressure ( > = 140/90), and 54.8% did not have a current primary care provider. This project demonstrated that conducting HCV and other health screenings at food distribution sites within Cherokee Nation was an effective strategy to engage AI/AN people in preventive health screenings. Future programs are needed to scale-up preventive health screenings outside of traditional medical facilities as these types of screenings may help to decrease the HCV disparities among AI/AN people.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health (social science)
Reference42 articles.
1. Centers for Disease Control and Prevention (2022). Hepatitis C. Retrieved January 11, 2023, from https://www.cdc.gov/hepatitis/statistics/2020surveillance/hepatitis-c.htm 2. Centers for Disease Control and Prevention (2022). 2020 Viral Hepatitis Surveillance Report, Table 3.2 – Acute – Cases & Rates by Demographics. Retrieved January 11, 2023, from https://www.cdc.gov/hepatitis/statistics/2020surveillance/hepatitis-c/table-3.2.htm 3. Centers for Disease Control and Prevention (2022). 2020 Viral Hepatitis Surveillance Report, Table 3.8 – Death Rates by Demographics. Retrieved January 11, 2023, from https://www.cdc.gov/hepatitis/statistics/2020surveillance/hepatitis-c/table-3.8.htm 4. Saine, M. E., Szymczak, J. E., Moore, T. M., Bamford, L. P., Barg, F. K., Schnittker, J., Holmes, J. H., Mitra, N., & Lo Re, I. I. I., V (2020). Determinants of stigma among patients with hepatitis C virus infection. Journal of Viral Hepatitis, 27(11), 1179–1189. https://doi.org/10.1111/jvh.13343 5. Harris, M., Guy, D., Picchio, C. A., White, T. M., Rhodes, T., & Lazarus, J. V. (2021). Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research. International Journal of Drug Policy, 96, 103320. https://doi.org/10.1016/j.drugpo.2021.103320
|
|